| Mary Lindsay Lovelace, MS, CCC-SLP | |
|
741 N Wood Ave, Florence, AL 35630-3402 | |
| (256) 627-2065 | |
| Not Available |
| Full Name | Mary Lindsay Lovelace |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 741 N Wood Ave, Florence, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730755455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 14408712 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Lindsay Lovelace, MS, CCC-SLP 741 N Wood Ave, Florence, AL 35630-3402 Ph: (256) 627-2065 | Mary Lindsay Lovelace, MS, CCC-SLP 741 N Wood Ave, Florence, AL 35630-3402 Ph: (256) 627-2065 |
News Archive
Patients with a greater than 10 pack/year history of smoking tend to develop an especially dangerous form of head and neck squamous cell cancer for which prognosis remains poor and treatments have changed little during the past two decades.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that the audit report from its independent registered public accounting firm on its financial statements for the fiscal year ended December 31, 2009, included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2010, contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
Leaders from UNFPA, United Nations Population Fund, and CARE International announced today at the Women Deliver Conference an agreement to enhance collaboration on maternal health programs in more than 25 countries. This unique collaboration will bring together UNFPA's effective work with national governments and CARE's expertise in engaging local communities.
› Verified 4 days ago
Anna Brooke Irons, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 143 Ana Dr, Florence, AL 35630 Phone: 256-767-1576 | |
Raegan Caroline Mcinnish, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 405 E Dr Hicks Blvd, Florence, AL 35630 Phone: 256-767-1576 Fax: 256-767-1577 | |
Mrs. Audrey Meadows, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 728 Sherrod Ave, Florence, AL 35630 Phone: 205-903-0491 | |
Molly Moore Bennett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 143 Ana Dr, Florence, AL 35630 Phone: 256-767-1576 | |
Cynthia J Pepper, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 416 N Seminary St, Suite 1000, Florence, AL 35630 Phone: 256-764-9001 | |
Mrs. Margaret Ellouise Berryman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 405 E Dr Hicks Blvd, Florence, AL 35630 Phone: 256-767-1576 | |
Kathryn Rose King, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 143 Ana Dr, Florence, AL 35630 Phone: 256-767-1576 |